CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

SUN PHARMACEUTICAL INDUSTRIES INC recalls DOXOrubin Hydrochloride…

SUN PHARMACEUTICAL INDUSTRIES INC recalls DOXOrubin Hydrochloride Liposome injection

Read the official FDA notice

Published
17 Jun 2026
Units affected
675 vials
Agency
FDA
Country
United States

The hazard

Presence of Particulate matter: Particulate matter identified as glass.

Classification: Class I — the most serious type: there is a reasonable chance this product could cause serious health problems or death.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile, Rx only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol, Gujarat, India, NDC 72603-200-01.

Brand / company
SUN PHARMACEUTICAL INDUSTRIES INC
Codes / lots
Lot HAG2581B, expires: 05/31/2027
Distribution
U.S. Nationwide
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 17 Jun 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.